INTRODUCTION
Neuroendocrine (NE) carcinoma is derived from the NE cells that are scattered throughout all the organ systems, and these NE cells are particularly prevalent in the bronchopulmonary and gastrointestinal tract. (1) Primary NE carcinoma of the breast is extremely rare and it accounts for less than 0.1% of all breast carcinomas, less than 1% of all NE neoplasms in the body and only 0.1% of all breast cancers.(1) However, NE differentiation has also been described in a subset of patients with typical breast carcinoma and the clinical and histopathological features of these patients overlap with those of primary NE carcinoma. ( 
CASE REPORT
A 72-yr-old-woman presented at our institution with a painless lump in her left breast that she first noticed a few weeks ago. She described no nipple discharge. On the physical examination, an elastic, firm, indistinct mass with a diameter of 2 cm was palpated in the upper outer quadrant of the breast 3 cm away from the areola. There was no retraction or dimpling, however, axillary lymphadenopathy with any fixation was present.
The mammograhy revealed an irregular, lobulated, high density mass (3×2.5 cm) with microcalcifications in the upper outer quadrant of the left breast and this was highly suspicious for malignancy (BI-RADS 5) ( Figure   1 ). The second lesion (1.5×1.5 cm) with a calcified appearance was also noted on the mammogram, and this second leson was adjacent to the first and located in the same area ( Figure 1 ). Ultrasonography (US) also showed two distinct irregular lumps that had heterogeneous echoes with increased vascularity and microlobuted margins, Primary neuroendocrine carcinoma of the breast is an extremely rare neoplasm that differs from other types of breast carcinoma according to the pathological features. We describe here a case of primary neuroendocrine carcinoma in a 72year-old woman who complainted of a lump in her left breast. After examination and evaluation, the diagnosis was made by a core needle biopsy and the subsequent immunohistochemical examination of the specimen revealed more detailed information. We performed modified radical mastectomy, which showed no axillary node involvement. The patient was given neither radiation nor chemotherapy, however, but hormonotherapy was started postoperatively. Any recurrence has not been demonstrated at 12 months after the operation.
the same as was seen on the mammography. Lymphadenopathy with a minimally thickened cortex was visualised in the axilla and the largest lymph node was measured 23×10 mm. The laboratory data including the serum tumor markers such as CEA, CA 15-3, etc, and the other blood tests were within normal limits. A core needle biopsy of the palpable mass was performed and she was diagnosed with invasive primary neuroendocrine carcinoma. Thus, we performed a modified radical mastectomy with complete axillary lymph node dissection.
A definitive histopathological examination revealed that the tumor was composed of solid nests and sheets consisting of infiltrating small polygonal or oval cells with hyperchromatic nuclei, scant cytoplasm and rare mitoses.
The tumor cells were dispersed in solid sheet-like trabecular patterns separated by fibrous stroma (Figure 2A Figure 3A, B) . The Ki-67 proliferation index showed very low activity (<10%) in the tumor cells ( Figure   3C ). Estrogen and progesterone receptors (ER/PR) were nuclear ( Figure 4 ) and E-cadherin was membranous positive. However, the c-erb-B2 expression was negative.
It was found that it was a solid neuroendocrine carci- 
